2016
DOI: 10.1016/j.actbio.2016.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring mechanical properties of decellularized extracellular matrix bioink by vitamin B2-induced photo-crosslinking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
237
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 282 publications
(239 citation statements)
references
References 30 publications
2
237
0
Order By: Relevance
“…These include 2,20-Azobis[2-methyl-N-(2-hydroxyethyl) propionamide] (VA086), vitaminB2 27 and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). Whilst photo cross-linking with very high cell viability has indeed been achieved using VA086 28 , this again required very low-intensity exposure to 365 nm UV-A at 4 mW/cm 2 (again, unacceptably long exposure time requirements for our purposes).…”
Section: Discussionmentioning
confidence: 99%
“…These include 2,20-Azobis[2-methyl-N-(2-hydroxyethyl) propionamide] (VA086), vitaminB2 27 and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). Whilst photo cross-linking with very high cell viability has indeed been achieved using VA086 28 , this again required very low-intensity exposure to 365 nm UV-A at 4 mW/cm 2 (again, unacceptably long exposure time requirements for our purposes).…”
Section: Discussionmentioning
confidence: 99%
“…Following this study, the same group showed that the dECM bioink can be pre-gelled using vitamin B2-induced covalent cross-linking (Jang et al, 2016a,b,c). Using this approach, a 3D printed cardiac patch composed of multiple-cell lines including human cardiac progenitor cells and mesenchymal stem cells was developed (Jang et al, 2016a,b,c). Although dECM bioinks provide novel opportunities to fabricate tissue specific constructs, the decellularization process requires multiple steps including precise quantification of the DNA and the ECM components, making it a costly approach.…”
Section: Currently Available Bioinksmentioning
confidence: 96%
“…3D printing has a strong potential to become a common fabrication technique in medicine as it enables fabrication of modular and patient-specific scaffolds and devices, and tissue models, with high structural complexity and design flexibility (Murphy and Atala, 2014; Jang et al, 2016a,b,c; Kang et al, 2016; Kuo et al, 2016; Zhang et al, 2016). There is a significant interest in designing novel bioink formulations toward the goal of achieving the “ideal” bioink for each bioprinting technology (Hölzl et al, 2016).…”
Section: Summary and Future Perspectivesmentioning
confidence: 99%
“…In this versatile technology, cell-laden polymeric solutions [28,154], decellularized ECM components [73], cell suspensions [68], microcarriers [162] or tissue spheroids [185] are loaded into standard disposable syringes, and printed onto a building platform driven by pneumatic (pressurized air), mechanical (piston or screw) or solenoid (electrical pulses)-based dispensing systems [76,111,125,137]. An important advantage of extrusion bioprinting is the ability to print highly viscous polymer solutions containing a wide range of cell densities (up 10 7 cells mL -1 ) [92,182].…”
Section: Extrusion Bioprintingmentioning
confidence: 99%